ELIZABETH CHOE: Open Payments
NPI 1063594380 · ORANGE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,242 in 173 payments from 18 companies in 2025. Trend: 2023 $3,111 · 2024 $3,536 · 2025 $4,242
Food & beverage: $4,143Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 27 | $622 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $557 |
| UCB, Inc. | 19 | $511 |
| PFIZER INC. | 24 | $470 |
| Janssen Biotech, Inc. | 12 | $381 |
| ABBVIE INC. | 20 | $349 |
| Organon LLC | 12 | $294 |
| Galderma Laboratories, L.P. | 7 | $249 |
| Lilly USA, LLC | 9 | $159 |
| GENZYME CORPORATION | 3 | $155 |
Products named: OPZELURA, Bimzelx, CIBINQO, ILUMYA, TREMFYA, DUPIXENT, NEMLUVIO, SKYRIZI.
Industry payments across CT — which companies pay providers there.
